TechMD Announces its Acquisition by Integris
ENDICOTT, N.Y.--(BUSINESS WIRE)--TechMD, a leading provider of cybersecurity and IT managed services, announced today that it has been acquired by Integris, a national leader in IT managed services. TechMD has been backed by ClearLight Partners, a private equity firm based in Newport Beach, California. Integris is backed by OMERS Private Equity. The financial terms of the transaction were not disclosed.
'We are excited for this new chapter at TechMD,' Kevin Blake, TechMD's CEO, shared. 'We are impressed with the Integris team and know they will be a world-class partner. We are confident that together we can provide outstanding service to our clients, while also investing in our people and processes to continue to evolve and deliver a superior client experience.'
Michael Kaye, Founding Partner of ClearLight said, 'Kevin and his team have done a great job of protecting and servicing clients, and have grown the company well. It has been a great pleasure to work with them. We are excited to see their continued success as part of the larger Integris organization.'
Kyle Burke, Partner of ClearLight Partners, added, 'Early on, we identified tailwinds in the IT managed services industry and believed TechMD was well positioned to capitalize on them. The team executed, driving strong retention and organic growth, while staying ahead of the curve to provide compelling value to clients. This gave us the confidence to continue to grow organically and through a series of add-on acquisitions, leading to a great outcome.'
TechMD and ClearLight Partners were advised by Guggenheim Securities, LLC, Kirkland & Ellis, LLP, and Hinman, Howard & Kattell.
About TechMD
Founded in 1986 and with offices in New York, California, Massachusetts, and Maryland, TechMD provides managed IT and cybersecurity services under the 1nteger Security brand, along with strategic IT consulting. TechMD has succeeded in helping clients and their communities by taking care of IT needs so that they can focus on their businesses.
About Integris
Integris is a national leader in future-ready managed services, delivering innovative solutions that drive digital maturity for small to midsize businesses. We go beyond traditional IT management by delivering strategic roadmaps that optimize operations, strengthen cybersecurity, refine cloud solutions, and ensure compliance—all while enhancing our client's digital capabilities. Our goal is to transform each organization into a smarter and faster digital powerhouse. Our platform is responsive, secure, and ready to meet the unique regulatory demands of the industries we serve. Regularly featured on the Inc. 5000 list of fastest-growing companies, Integris is backed by the private equity arm of the Ontario Municipal Employees Retirement System (OMERS). For more information, visit integrisit.com.
About ClearLight Partners
ClearLight Partners is a private equity firm in Newport Beach, California that invests in established, profitable middle-market companies with significant growth potential. Since its inception, ClearLight has raised $900 million in capital across three funds from a single limited partner. The team at ClearLight has extensive operating and financial experience and has a history of successfully partnering with owners and management teams to drive growth and create value. For more information, please visit www.clearlightpartners.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
2 hours ago
- Business Insider
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases, today announced that on June 10, 2025, the company granted inducement awards to seventeen new employees. The grants were made pursuant to Nurix's 2024 Equity Inducement Plan as an inducement material to the employees' acceptance of employment with Nurix and were approved by the Compensation Committee of Nurix's Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4). The company granted stock options to purchase an aggregate of 97,400 shares of Nurix common stock and restricted stock unit awards (RSUs) representing an aggregate of 66,750 shares of Nurix common stock. One fourth of the total number of shares underlying the stock options will vest on the one-year anniversary of the employee's date of hire and one forty-eighth of the total number of shares underlying the stock options will vest each month thereafter until the stock option is fully vested on the fourth anniversary of the employee's date of hire, subject to the employee's continued service with Nurix on each such vesting date. The stock options have a term of ten years and an exercise price of $12.79 per share, which is equal to the closing price of Nurix's common stock on the grant date as reported by the Nasdaq Global Market. One fourth of the total number of shares subject to the RSUs will vest on the one-year anniversary of the RSU vesting start date, which is July 30, 2025, subject to the employee's continued service with Nurix on the vesting date. Thereafter, one sixteenth of the total number of shares subject to the RSUs shall vest quarterly, until the RSU award is fully vested on the fourth anniversary of the vesting start date, subject to the employee's continued service with Nurix on each such vesting date. About Nurix Therapeutics, Inc. Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Nurix's wholly owned, clinical stage pipeline includes degraders of Bruton's tyrosine kinase (BTK), a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene B (CBL-B), an E3 ligase that regulates activation of multiple immune cell types including T cells and NK cells. Nurix also is advancing multiple potentially first-in-class or best-in-class degraders and degrader antibody conjugates (DACs) in its preclinical pipeline. Nurix's partnered drug discovery pipeline consists of preclinical stage degraders of IRAK4 and STAT6, as well as multiple additional programs under collaboration agreements with Gilead Sciences, Inc., Sanofi S.A. and Pfizer Inc., within which Nurix retains certain options for co-development, co-commercialization and profit sharing in the United States for multiple drug candidates. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix's dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine's next chapter with a new script to outmatch disease. Nurix is headquartered in San Francisco, California. For additional information visit Elizabeth Wolffe, Ph.D. Wheelhouse Life Science Advisors lwolffe@ Media Aljanae Reynolds Wheelhouse Life Science Advisors areynolds@
Yahoo
4 hours ago
- Yahoo
TechMD Announces its Acquisition by Integris
ENDICOTT, N.Y., June 17, 2025--(BUSINESS WIRE)--TechMD, a leading provider of cybersecurity and IT managed services, announced today that it has been acquired by Integris, a national leader in IT managed services. TechMD has been backed by ClearLight Partners, a private equity firm based in Newport Beach, California. Integris is backed by OMERS Private Equity. The financial terms of the transaction were not disclosed. "We are excited for this new chapter at TechMD," Kevin Blake, TechMD's CEO, shared. "We are impressed with the Integris team and know they will be a world-class partner. We are confident that together we can provide outstanding service to our clients, while also investing in our people and processes to continue to evolve and deliver a superior client experience." Michael Kaye, Founding Partner of ClearLight said, "Kevin and his team have done a great job of protecting and servicing clients, and have grown the company well. It has been a great pleasure to work with them. We are excited to see their continued success as part of the larger Integris organization." Kyle Burke, Partner of ClearLight Partners, added, "Early on, we identified tailwinds in the IT managed services industry and believed TechMD was well positioned to capitalize on them. The team executed, driving strong retention and organic growth, while staying ahead of the curve to provide compelling value to clients. This gave us the confidence to continue to grow organically and through a series of add-on acquisitions, leading to a great outcome." TechMD and ClearLight Partners were advised by Guggenheim Securities, LLC, Kirkland & Ellis, LLP, and Hinman, Howard & Kattell. About TechMD Founded in 1986 and with offices in New York, California, Massachusetts, and Maryland, TechMD provides managed IT and cybersecurity services under the 1nteger Security brand, along with strategic IT consulting. TechMD has succeeded in helping clients and their communities by taking care of IT needs so that they can focus on their businesses. About Integris Integris is a national leader in future-ready managed services, delivering innovative solutions that drive digital maturity for small to midsize businesses. We go beyond traditional IT management by delivering strategic roadmaps that optimize operations, strengthen cybersecurity, refine cloud solutions, and ensure compliance—all while enhancing our client's digital capabilities. Our goal is to transform each organization into a smarter and faster digital powerhouse. Our platform is responsive, secure, and ready to meet the unique regulatory demands of the industries we serve. Regularly featured on the Inc. 5000 list of fastest-growing companies, Integris is backed by the private equity arm of the Ontario Municipal Employees Retirement System (OMERS). For more information, visit About ClearLight Partners ClearLight Partners is a private equity firm in Newport Beach, California that invests in established, profitable middle-market companies with significant growth potential. Since its inception, ClearLight has raised $900 million in capital across three funds from a single limited partner. The team at ClearLight has extensive operating and financial experience and has a history of successfully partnering with owners and management teams to drive growth and create value. For more information, please visit View source version on Contacts Kyle BurkePartner at ClearLight Partnerskpb@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
TechMD Announces its Acquisition by Integris
ENDICOTT, N.Y., June 17, 2025--(BUSINESS WIRE)--TechMD, a leading provider of cybersecurity and IT managed services, announced today that it has been acquired by Integris, a national leader in IT managed services. TechMD has been backed by ClearLight Partners, a private equity firm based in Newport Beach, California. Integris is backed by OMERS Private Equity. The financial terms of the transaction were not disclosed. "We are excited for this new chapter at TechMD," Kevin Blake, TechMD's CEO, shared. "We are impressed with the Integris team and know they will be a world-class partner. We are confident that together we can provide outstanding service to our clients, while also investing in our people and processes to continue to evolve and deliver a superior client experience." Michael Kaye, Founding Partner of ClearLight said, "Kevin and his team have done a great job of protecting and servicing clients, and have grown the company well. It has been a great pleasure to work with them. We are excited to see their continued success as part of the larger Integris organization." Kyle Burke, Partner of ClearLight Partners, added, "Early on, we identified tailwinds in the IT managed services industry and believed TechMD was well positioned to capitalize on them. The team executed, driving strong retention and organic growth, while staying ahead of the curve to provide compelling value to clients. This gave us the confidence to continue to grow organically and through a series of add-on acquisitions, leading to a great outcome." TechMD and ClearLight Partners were advised by Guggenheim Securities, LLC, Kirkland & Ellis, LLP, and Hinman, Howard & Kattell. About TechMD Founded in 1986 and with offices in New York, California, Massachusetts, and Maryland, TechMD provides managed IT and cybersecurity services under the 1nteger Security brand, along with strategic IT consulting. TechMD has succeeded in helping clients and their communities by taking care of IT needs so that they can focus on their businesses. About Integris Integris is a national leader in future-ready managed services, delivering innovative solutions that drive digital maturity for small to midsize businesses. We go beyond traditional IT management by delivering strategic roadmaps that optimize operations, strengthen cybersecurity, refine cloud solutions, and ensure compliance—all while enhancing our client's digital capabilities. Our goal is to transform each organization into a smarter and faster digital powerhouse. Our platform is responsive, secure, and ready to meet the unique regulatory demands of the industries we serve. Regularly featured on the Inc. 5000 list of fastest-growing companies, Integris is backed by the private equity arm of the Ontario Municipal Employees Retirement System (OMERS). For more information, visit About ClearLight Partners ClearLight Partners is a private equity firm in Newport Beach, California that invests in established, profitable middle-market companies with significant growth potential. Since its inception, ClearLight has raised $900 million in capital across three funds from a single limited partner. The team at ClearLight has extensive operating and financial experience and has a history of successfully partnering with owners and management teams to drive growth and create value. For more information, please visit View source version on Contacts Kyle BurkePartner at ClearLight Partnerskpb@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
